Description: Provision of CT Radiopharmaceuticals -Nanotop, MAG3, Tektrotyd, Illuccix

Description: Provision 2 x ELITe BeGenius ACE PCR analysers and bring testing in house

Description: Provision of radiopharmaceuticals

Description: Provision of Radiopharmaceuticals

Description: Provision of Radiopharmaceuticals

Description: Provision of Radiopharmaceuticals

Description: the supply of FDG tracers used for PET-CT's in privately funded patients and research.

Description: the supply of FDG tracers used for PET-CT's in privately funded patients and research.

Description: Provision of reagent equipment and consumables

Description: Provision of Building Energy Management System (BEMS) consultancy services, including strategy development, technical review, standards development, tender support and project oversight across the Trust’s estate

Description: The procurement of a next-generation sequencing (NGS)–based test assay designed for the detection and monitoring of minimal residual disease (MRD) in patients with certain haematologic malignancies, such as multiple myeloma, acute lymphoblastic leukaemia (ALL), and chronic lymphocytic leukaemia (CLL). The required good...

Description: Provision of independent Lifts Authorising Engineer services, including statutory compliance assurance, technical advice, inspection oversight, certification review, and support to ensure safe operation and compliance with relevant legislation and standards across the Trust’s estate.

Description: The procurement of a next-generation sequencing (NGS)–based test assay designed for the detection and monitoring of minimal residual disease (MRD) in patients with certain haematologic malignancies, such as multiple myeloma, acute lymphoblastic leukaemia (ALL), and chronic lymphocytic leukaemia (CLL). The required good...

Description: To provide an independent, practical and NHSE/HMT-aligned assessment of the regulatory, legal, employment, commercial and tax risks and mitigations associated with the proposed wholly owned subsidiary (WOS)

Description: Contract for Netspot Kits required by the trust

Description: Contract for Netspot Kits required by the trust

Description: The Royal Marsden is currently exploring alternative operating models for its microbiology services and is undertaking a market engagement exercise to gather insights from providers. The exercise is designed to be a fact-finding and there is no formal evaluation. Providers are encouraged to propose individual solution...

Description: The Royal Marsden is currently exploring alternative operating models for its microbiology services and is undertaking a market engagement exercise to gather insights from providers. The exercise is designed to be a fact-finding and there is no formal evaluation. Providers are encouraged to propose individual solution...

Description: The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic service and are incorporated into Standard Operating Procedures.

Description: CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific age group is a clinical one that would be decided by a Multi-Discipli...

Description: The Authority is seeking to procure a new Clinical Trial Data Management Solution. The primary objective of this solution is to provide an accessible and cost-effective service that enables The Royal Marsden to collect and manage clinical research data in full compliance with relevant regulatory standards, while suppor...

Description: The purchasing of a Nonacus GALEAS HereditaryPlus panel and GALEAS HereditaryPlus Variant Calling with field application scientist support

Description: The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic service and are incorporated into Standard Operating Procedures.

Description: The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic service and are incorporated into Standard Operating Procedures.

Description: The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic service and are incorporated into Standard Operating Procedures.

Description: Direct Award A - single source

Description: Urgent award - PSR<br/>Being awarded to incumbent provider and will procure next year <br/>SWLP shall provide a comprehensive diagnostic pathology service for specimens received from the Purchaser.

Description: for the the supply of paediatric bone marrow harvests- a highly specialist procedure that’s conducted in a limited number of Trusts within the UK for our cohort of Paediatric patients (under 12KG), under 5 other UK Trusts.

Description: The overarching aim of this solution is to deliver an accessible and cost-effective service, which enables The Royal Marsden to collect and manage clinical research data in compliance with regulatory standards and to maintain UKCRC CTU accreditation.

Description: The overarching aim of this solution is to deliver an accessible and cost-effective service, which enables The Royal Marsden to collect and manage clinical research data in compliance with regulatory standards and to maintain UKCRC CTU accreditation.

Description: SLA between NHS Blood & Transplant (supplier) and RMH (customer) for the the provision of Extracorporeal Photopheresis services for the treatment of chronic and acute Graft versus Host Disease (GvHD) and Cutaneous T-Cell Lymphoma. Extracorporeal photopheresis is a procedure which utilises an integrated closed system to...

Description: The Royal Marsden Hospital NHS Foundation Trust ("the Authority") required the provision of Non-Emergency Patient Transport Services.<br/>The Authority intends to award a contract, following a Direct Award - Process C, in accordance with The Health Care Services (Provider Selection Regime) Regulations 2023 (“PSR 2023”)...

Description: Chelsea and Westminster Hospital NHS Foundation Trust ("the Authority") required the provision of Non-Emergency Patient Transport Services.<br/>The Authority intends to award a contract, following a Direct Award - Process C, in accordance with The Health Care Services (Provider Selection Regime) Regulations 2023 (“PSR ...